ABT Trade Setup: Breakout Play with 10.6% Upside

🏥 Abbott Labs (ABT) Trade Alert
Positioning in this healthcare giant as it breaks out from consolidation - here's the strategic play:

📌 Trade Levels
▶ Entry: $133.12 (confirmed above SMA 50)
🎯 Target: $147.21 (+10.6%)
🛑 Stop Loss: $126.00 (-5.3% risk)
⚖️ Risk/Reward: 1:2

Why ABT Now?
✅ Fundamental Strength:

Net Income Growth: "Strong growth" (+134% YoY in last report)

Dividend Aristocrat: 50+ years of dividend growth (current yield 1.9%)

Debt Health: Score 10/10 (Debt/Equity 0.26, Interest Coverage 15x)

✅ Technical Triggers:

Bullish crossover (50D > 200D MA)

RSI 55 - neutral with room to run

Volume surge on $132 breakout

Measured move target aligns with $147 zone

📊 Trade Management:

Entry: $133.12 (market price)

Scale In: Add at $130 if tested

Adjust Stop: Move to breakeven at $136

Partial Profit: Take 50% at $140

⚠️ Key Risks:

Sector rotation out of healthcare

FDA delays on new devices

Strong resistance at $138 (prior highs)

ABT dominates 4 growth segments:

Medical Devices (44% revenue)

Diagnostics (32%)

Nutrition (12%)

Generics (12%)
Recent FDA approval for Freestyle Libre 3 drives upside.

Trade active until next earnings (Oct 18). Let me know your take! 👇

#HealthcareStocks #DividendInvesting #BreakoutTrade